Physician profile
Kimpreet Kaur
NPI 1033642962
$7,133.64
in general payments reported to CMS, 2019-2025
12 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $71.24 · 2021: $117 · 2022: $705 · 2023: $3,503 · 2024: $2,484 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,245 · Food and Beverage: $2,996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,245.32 |
| Food and Beverage | $2,995.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,962.28 | 2020-2024 | Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,615.46 | 2023-2024 | Proclaim, Eterna |
| Spinal Simplicity, LLC | $942.40 | 2023 | Ha Minuteman G3-R |
| Medtronic, INC. | $903.58 | 2021-2024 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $416.80 | 2023 | Intracept |
| Nevro Corp. | $357.73 | 2023 | Senza |
| Aerin Medical INC. | $301.19 | 2024-2025 | |
| Avanos Medical | $193.29 | 2023-2025 | Generator, Coolief Cooled Radiofrequency |
| Mml US, INC. | $127.06 | 2023 | Reactiv8 |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Smith+Nephew, INC. | $109.40 | 2024 | Stravix |
| Depuy Synthes Sales INC. | $87.50 | 2025 | Matrixmandible, Matrixorthognathic, Matrixwave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimpreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.